GlassScriptDysis Ultra 2.0
Payments companies reported to CMS as associated with Dysis Ultra 2.0. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Dysis Ultra 2.0, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Dysis Ultra 2.0
These are the largest totals companies reported as associated with Dysis Ultra 2.0. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Diana Herrera | Houston, TX | Obstetrics & Gynecology | $132.93 |
| Alia Shbeeb | Riverside, CA | Obstetrics & Gynecology | $124.28 |
| Sanaz Amini | Loma Linda, CA | Obstetrics & Gynecology | $124.28 |
| Deborah Arden | Boston, MA | $124.28 | |
| Alireza Abidi | Sacramento, CA | Gynecologic Oncology | $124.28 |
| Sabah Langston | Riverside, CA | Obstetrics & Gynecology | $124.27 |
| Mazdak Momeni | Loma Linda, CA | Gynecologic Oncology | $124.27 |
| Jennifer Chou-Kim | Riverside, CA | Obstetrics & Gynecology | $124.27 |
| Janet Zhang | Riverside, CA | Obstetrics & Gynecology | $124.27 |
| Mehdi Moslemi-Kebria | Upland, CA | Gynecologic Oncology | $124.27 |
Prescribed Dysis Ultra 2.0?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.